Hal Allergy
Netherlands - Leiden
BiotechnologyFocus: Allergy Treatments
Hal Allergy is a life sciences company focused on Allergy Treatments.
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
HAL-MPE1
Peanut AllergyClinical Trials (1)
NCT02991885HAL-MPE1 Safety and Tolerability Study
Phase 1HAL-MPE1
Peanut AllergyClinical Trials (1)
NCT02163018HAL-MPE1 First-in-human
Phase 1HAL-MRE1
Rhinitis, AllergicClinical Trials (1)
NCT03758456HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
Phase 1SUBLIVAC FIX Mite mixture
House Dust Mite AllergyClinical Trials (1)
NCT02345278SUBLIVAC FIX Mite Mixture Dose Tolerability Study
Phase 1/2sublingual immunotherapy
Seasonal Rhinitis and/or RhinoconjunctivitisClinical Trials (1)
NCT00932607SUBLIVAC® Birch PROBE Study
Phase 2Placebo
Allergic RhinitisClinical Trials (1)
NCT01438463PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis
Phase 2SUBLIVAC FIX Phleum Prat.
Allergic RhinitisClinical Trials (1)
NCT02556801Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
Phase 2SUBLIVAC FIX Birch
Allergic RhinitisClinical Trials (1)
NCT01639768SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
Phase 2PURETHAL Mites 20,000 AUeq/ml
Allergic RhinitisClinical Trials (1)
NCT00973453Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients
Phase 2SUBLIVAC FIX phleum prat.
Allergic RhinitisClinical Trials (1)
NCT01682070SUBLIVAC FIX Phleum Pratense DT/DRF
Phase 2SUBLIVAC FIX Birch
Birch Pollen Induced Rhinitis/RhinoconjunctivitisClinical Trials (1)
NCT02231307SUBLIVAC FIX Birch Phase III Short-term Efficacy
Phase 3PURETHAL Mites 50,000 AUeq/ml
House Dust Mite AllergyClinical Trials (1)
NCT06920771A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
Phase 3SUBLIVAC® Grasses/Placebo treatment
Rhinitis, Allergic, SeasonalClinical Trials (1)
NCT00422149Twin SUBLIVAC® Grasses Clinical Efficacy Study
Phase 3PURETHAL Birch, 20.000 AUM/ml
Allergic RhinitisClinical Trials (1)
NCT01918956PURETHAL Birch RUSH Study
Phase 4PURETHAL Grasses, 20.000 AUM/ml
Allergic RhinitisClinical Trials (1)
NCT01059266PURETHAL Grasses Rush Study
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2020
Portfolio: 15 clinical trials
Publications: 20 in PubMed